Appointment of new CEO
ANNOUNCEMENT NO. 254
Appointment of new CEO
The Board of Directors of ChemoMetec has decided
to appoint the company's current COO Martin Helbo Behrens as new
CEO, effective as of today.
The decision is based on the Board’s assessment
that ChemoMetec in the current phase of the company's development
needs a different composition of executive management skills.
Therefore, the board has entered into an agreement with the
company's current CEO Rasmus Kofoed to resign from his position as
of today.
Martin Helbo Behrens, who is 31 years old, has
been employed at ChemoMetec for a number of years. He was
originally employed as part of Group Finance, but in 2021 he
relocated to the USA to take up a position as first COO and then
CFO of ChemoMetec's American subsidiary. In these roles he has made
a significant contribution to ChemoMetec's high growth and
commercial success in the North American market over recent years.
After almost three years in the USA, Martin Helbo Behrens returned
to ChemoMetec's head office in Allerød as Deputy COO in 2023 and
took up the position as COO on 1 February 2024.
With Martin Helbo Behrens' in-depth insight into
ChemoMetec's organization, products and markets, and based on the
results he has contributed to creating in ChemoMetec, the Board is
convinced that Martin Helbo Behrens will be the right profile to
head ChemoMetec as CEO in the future.
CEO Martin Helbo Behrens and CFO Niels Høy
Nielsen will hereafter form the executive management of
ChemoMetec.
For further information
Chairman of the Board Niels Thestrup, ChemoMetec
A/SPhone: (+45) 3370 2000
About ChemoMetec A/S
ChemoMetec develops, manufactures and markets
instruments for cell counting and a wide range of other
measurements. ChemoMetec’s instruments are marketed to the
pharmaceutical, biotech and agricultural industries worldwide.
ChemoMetec’s customers include some of the world’s leading
pharmaceutical companies, such as Novartis, Novo Nordisk, H.
Lundbeck, Merck, AstraZeneca and Johnson & Johnson.
ChemoMetec was founded in 1997 and is listed on
the Nasdaq Copenhagen stock exchange. For more information, go to
www.chemometec.com
Grafico Azioni Chemometec AS (TG:CHY)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Chemometec AS (TG:CHY)
Storico
Da Feb 2024 a Feb 2025
